$7.08
0.24 (+3.51%)
Cambrex Corp (NYSE:CBM)
CAPS Rating:
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.